See the Glossary for more terms.
Some links will work for NIAID staff only.
This standard operating procedure (SOP) includes the following sections: Purpose, Procedure, Contacts, and Links.
To support a two-phased award without a break in funding in which transition to the second phase depends on several factors, including the achievement of negotiated milestones.
An R21/R33 Phased Innovation Award has two phases: 1) R21 for milestone-driven exploratory or feasibility studies with a possible transition to 2) the R33 for expanded development.
Transition to the R33 depends on the applicant's completing milestones (which were evaluated in peer review and negotiated with NIAID program staff before the R21 was awarded) as well as program priorities and the availability of funds.
NIAID accepts R21/R33 applications in response to a program announcement (PA) or request for applications (RFA) only.
Use the following guidelines to prepare your application, accept your award, and transition to an R33.
Preparing the Application
Transition to the R33
Tamia PowellNational Institute of Allergy and Infectious Diseases 6700B Rockledge Drive, Room 2233 Bethesda, Maryland, 20892-7614
For internal roles, see the R21/R33 Phased Innovation Award Staff Roles SOP.
Phased Innovation Award Coordinator, Tamia Powell
Applicants with questions should read Communicating With NIAID—How to Get Help.
If you have knowledge to share or want more information on this topic, email firstname.lastname@example.org with the title of this page or its URL and your question or comment. Thanks for helping us clarify and expand our knowledge base.
Other Grant Types portal
Last Updated August 15, 2014
Last Reviewed August 15, 2014